Consulting Agreement, dated April 1, 2021 by and between Neuronetics, Inc. and Gregory Harper
This CONSULTING AGREEMENT (this “Agreement”), dated as April 1, 2021 (the “Effective Date”), is made by and between Neuronetics, Inc., a Delaware corporation (the “Company”), and Gregory Harper (“Consultant”). Consultant and the Company are sometimes individually referred to in this Agreement as a “Party” and collectively as the “Parties.”
Consultant retired from the role of the Company’s Vice President, R&D and clinical effective March 31, 2021; and
Company desires to utilize the services of Consultant in various capacities, including facilitation of the orderly transfer of Consultant’s former responsibilities, and Consultant is willing to perform such services for Company.
NOW, THEREFORE, in consideration of the foregoing premises and the promises and covenants set forth in this Agreement and intending to be legally bound hereby, the Company and Consultant agree as follows:
If to the Company, to:
3222 Phoenixville Pike
Malvern, PA 19355
Attention: General Counsel
If to Consultant, to:
or to such other names, addresses and/or facsimile numbers as the Company or Consultant, as the case may be, shall designate by notice to the other person in the manner specified in this Section.
IN WITNESS WHEREOF, the undersigned have executed this Agreement as of the Effective Date.
By: /s/ Keith J. Sullivan
Name:Keith J. Sullivan
Title:President and Chief Executive Officer
By: /s/ Gregory Harper
Name: Gregory Harper